Sky-mobi (MOBI) Is Today's Dead Cat Bounce Stock

 

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

 

Trade-Ideas LLC identified Sky-mobi ( MOBI) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Sky-mobi as such a stock due to the following factors:

 

 

  • MOBI has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $14.4 million.
  • MOBI has traded 74,212 shares today.
  • MOBI is up 3.5% today.
  • MOBI was down 5.9% yesterday.

 

EXCLUSIVE OFFER: Get the inside scoop on opportunities in MOBI with the Ticky from Trade-Ideas. See the FREE profile for MOBI NOW at Trade-Ideas

 

 

More details on MOBI:

 

Sky-mobi Limited, through its subsidiaries, is engaged in the operation of a mobile application platform embedded on mobile phones to provide mobile application store and services in the People's Republic of China. MOBI has a PE ratio of 83.2.

 

The average volume for Sky-mobi has been 664,500 shares per day over the past 30 days. Sky-mobi has a market cap of $253.8 million and is part of the technology sector and computer software & services industry. Shares are up 114.5% year-to-date as of the close of trading on Thursday.

 

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

 

null

More from Markets

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)